Bruckheimer E, Bulbul Z, Pinter E, Gailani M, Kleinman C S, Fahey J T
Section of Pediatric Cardiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Pediatr Cardiol. 1998 Nov-Dec;19(6):477-9. doi: 10.1007/s002469900362.
The successful use of nitric oxide (NO) inhalation in a critically ill neonate with Ebstein's anomaly of the tricuspid valve is reported for the first time. This use of inhaled NO therapy suggests a therapeutic intervention that directly addresses the pathophysiologic process of severe neonatal Ebstein's anomaly.